[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research …

W Zhang, G Nuki, RW Moskowitz, S Abramson… - Osteoarthritis and …, 2010 - Elsevier
OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 …

Current treatment options for osteoarthritis

W Hermann, S Lambova… - Current rheumatology …, 2018 - ingentaconnect.com
Osteoarthritis (OA) is the most common joint disease and a leading cause for impaired
function and disability with significant treatment costs and socio-economic burden. Despite …

Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis: a randomized clinical trial

LDA Paget, G Reurink, RJ de Vos, A Weir, MH Moen… - Jama, 2021 - jamanetwork.com
Importance Approximately 3.4% of adults have ankle (tibiotalar) osteoarthritis and, among
younger patients, ankle osteoarthritis is more common than knee and hip osteoarthritis. Few …

Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial

RJ De Vos, A Weir, HTM van Schie… - Jama, 2010 - jamanetwork.com
Context Tendon disorders comprise 30% to 50% of all activity-related injuries; chronic
degenerative tendon disorders (tendinopathy) occur frequently and are difficult to treat …

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

S Wandel, P Jüni, B Tendal, E Nüesch, PM Villiger… - Bmj, 2010 - bmj.com
Objective To determine the effect of glucosamine, chondroitin, or the two in combination on
joint pain and on radiological progression of disease in osteoarthritis of the hip or knee …

Chondroitin for osteoarthritis

JA Singh, S Noorbaloochi… - Cochrane Database …, 2015 - cochranelibrary.com
Background Osteoarthritis, a common joint disorder, is one of the leading causes of
disability. Chondroitin has emerged as a new treatment. Previous meta‐analyses have …

Glucosamine therapy for treating osteoarthritis

T Towheed, L Maxwell… - Cochrane database …, 2005 - cochranelibrary.com
Background Osteoarthritis (OA) is a common form of arthritis and is often associated with
significant disability and impaired quality of life. This is an update of a Cochrane review first …

Acupuncture for peripheral joint osteoarthritis

E Manheimer, K Cheng, K Linde, L Lao… - Cochrane database …, 2010 - cochranelibrary.com
Acupuncture for peripheral joint osteoarthritis - Manheimer, E - 2010 | Cochrane Library Skip to
Content Cookies Our site uses cookies to improve your experience. You can find out more …

The efficacy and safety of disease-modifying osteoarthritis drugs for knee and hip osteoarthritis—a systematic review and network meta-analysis

W Yang, C Sun, SQ He, JY Chen, Y Wang… - Journal of General …, 2021 - Springer
Background Osteoarthritis (OA) is common and burdensome for patients and health care
systems. Our study purpose was to evaluate the long-term efficacy and safety of DMOADs in …

[HTML][HTML] What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?

Y Henrotin, M Marty, A Mobasheri - Maturitas, 2014 - Elsevier
Chondroitin sulfate and glucosamine sulfate exert beneficial effects on the metabolism of in
vitro models of cells derived from synovial joints: chondrocytes, synoviocytes and cells from …